
MOTS-C 10mg β HD Laboratories
MOTS-C is a mitochondrial-derived peptide (MDP) researched for its role in cellular energy regulation and metabolic signaling. Naturally encoded within mitochondrial DNA, MOTS-C functions as a metabolic messenger that helps regulate stress adaptation, glucose utilization, and mitochondrial efficiency.
The 10mg vial by HD Laboratories contains high-purity lyophilized MOTS-C intended for laboratory and research applications.
Mechanism of Action
MOTS-C is classified as a mitochondrial βmitokineβ and primarily exerts its effects through metabolic signaling pathways:
AMPK Activation β Stimulates AMP-activated protein kinase, a key cellular energy sensor.
Enhanced Glucose Uptake β May promote improved glucose utilization at the cellular level.
Fatty Acid Oxidation Support β Encourages metabolic flexibility.
Nuclear Gene Regulation β Influences transcription factors associated with stress adaptation and metabolic balance.
Mitochondrial Efficiency β Supports cellular resilience under metabolic stress conditions.
Its mechanism makes it a peptide of interest in research related to metabolic health, body composition, endurance performance, and longevity pathways.
Potential Research Applications
While human clinical data remains limited, MOTS-C is commonly explored in research contexts for:
Metabolic optimization
Insulin sensitivity support
Body composition improvement
Exercise endurance and recovery
Healthy aging and mitochondrial support
All applications remain investigational.
Recommended Research Dosing Protocols
β There are no FDA-approved or clinically established human dosing guidelines for MOTS-C. The following reflects commonly observed research practices and community protocols.
General Administration
Route: Subcutaneous (SC) injection
Typical Dose Range: 5β10mg per administration
Frequency: 2β3 times per week
Cycle Duration: 4β12 weeks
Break Period: 4β8 weeks off between cycles
Storage: Refrigerate at 2β8Β°C after reconstitution
Goal-Specific Protocol Examples
1. Metabolic Optimization
Dose: 5β10mg
Frequency: 2β3Γ weekly
Timing: Morning or before meals
Cycle: 8β12 weeks
Intended to align with circadian metabolic signaling and glucose regulation pathways.
2. Body Composition & Fat Oxidation
Dose: ~10mg per week (split into 2β3 injections)
Timing: 30β60 minutes before exercise
Cycle: 8β12 weeks
Often paired with structured nutrition and resistance training protocols.
3. Endurance & Athletic Performance
Dose: 10mg weekly (divided doses)
Timing: 30β60 minutes pre-workout
Cycle: 6β8 weeks
Explored for its interaction with exercise-induced AMPK activation.
4. Longevity & Mitochondrial Research
Dose: 5β10mg weekly
Frequency: 2Γ weekly
Cycle: 10β12+ weeks
Focuses on mitochondrial stress resilience and metabolic health pathways.
Timing Considerations
Morning administration may align with fasting metabolic activity.
Pre-workout dosing is often utilized to synergize with exercise-induced metabolic activation.
Consistency in weekly timing appears more important than exact hour of administration.
Administration Guidelines
Reconstitute with bacteriostatic water using sterile technique.
Inject subcutaneously using an insulin syringe.
Rotate injection sites (abdomen, thigh, upper arm).
Do not shake vigorously during reconstitution.
Discard if solution becomes cloudy or discolored.